Cytek Biosciences, Inc. CTKB Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s total cost of revenue?
- Cytek Biosciences, Inc. (CTKB) reported total cost of revenue of $22.88M in Q1 2026.
- How has Cytek Biosciences, Inc.'s total cost of revenue changed year-over-year?
- Cytek Biosciences, Inc.'s total cost of revenue increased by 7.4% year-over-year, from $21.3M to $22.88M.
- What is the long-term trend for Cytek Biosciences, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s total cost of revenue has grown at a 18.7% compound annual growth rate (CAGR), from $48.81M to $97.03M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.